• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Demonstration of interleukin 8 in serum samples of patients with localized scleroderma.

作者信息

Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K

出版信息

Arch Dermatol. 1994 Oct;130(10):1327-8.

PMID:7944520
Abstract
摘要

相似文献

1
Demonstration of interleukin 8 in serum samples of patients with localized scleroderma.
Arch Dermatol. 1994 Oct;130(10):1327-8.
2
[Hemostasis in patients with circumscribed and systemic scleroderma].[局限性和系统性硬皮病患者的止血情况]
Vestn Dermatol Venerol. 1988(1):41-3.
3
[Differential blood pictures in progressive and circumscribed scleroderma].
Dermatol Monatsschr. 1972 Jun;158(6):417-20.
4
[Serum proteins in sclerodermia (author's transl)].
Cesk Dermatol. 1980 Oct;55(5):295-300.
5
Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma.局限性硬皮病患者血清中白细胞介素-2、白细胞介素-4和白细胞介素-6的检测
Arch Dermatol Res. 1995;287(2):193-7. doi: 10.1007/BF01262331.
6
Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma.
Dermatology. 1992;184(3):233-4. doi: 10.1159/000247555.
7
Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.局限性硬皮病患者血清可溶性白细胞介素-2受体水平的临床意义
Br J Dermatol. 1996 May;134(5):843-7.
8
[Some data on the cytochemistry of peripheral blood neutrophils in scleroderma].[硬皮病外周血中性粒细胞细胞化学的一些数据]
Sov Med. 1971 May;34(5):36-9.
9
Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.局限性硬皮病患者血清中可溶性白细胞介素6受体和可溶性gp130水平升高。
J Rheumatol. 2000 Aug;27(8):1917-21.
10
The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis.
Rom J Intern Med. 1998 Jul-Dec;36(3-4):251-9.

引用本文的文献

1
Interferon-Gamma-Inducible Protein-10 (IP-10) and Tumor Necrosis Factor-α (TNF-α) as Serological Predictors of Active Disease Status in Localized Scleroderma.干扰素-γ诱导蛋白-10（IP-10）和肿瘤坏死因子-α（TNF-α）作为局限性硬皮病活动疾病状态的血清学预测指标。
Int J Mol Sci. 2024 Sep 21;25(18):10134. doi: 10.3390/ijms251810134.
2
Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea.局限性硬皮病患者血清中特定白细胞介素-1家族细胞因子的水平
J Clin Med. 2022 Oct 28;11(21):6375. doi: 10.3390/jcm11216375.
3
Morphea: progress to date and the road ahead.
硬斑病：迄今进展与未来之路
Ann Transl Med. 2021 Mar;9(5):437. doi: 10.21037/atm-20-6222.
4
Cross-Disease Innate Gene Signature: Emerging Diversity and Abundance in RA Comparing to SLE and SSc.跨疾病固有基因特征：与 SLE 和 SSc 相比，RA 中的新兴多样性和丰度。
J Immunol Res. 2019 Jul 16;2019:3575803. doi: 10.1155/2019/3575803. eCollection 2019.
5
Immunopathogenesis of Pediatric Localized Scleroderma.儿童局限性硬皮病的免疫发病机制。
Front Immunol. 2019 Apr 30;10:908. doi: 10.3389/fimmu.2019.00908. eCollection 2019.
6
Methotrexate: an effective monotherapy for refractory generalized morphea.甲氨蝶呤：难治性泛发性硬斑病的有效单一疗法。
Clin Cosmet Investig Dermatol. 2017 May 8;10:165-169. doi: 10.2147/CCID.S134879. eCollection 2017.
7
Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea.转录和细胞因子谱将CXCL9鉴定为硬斑病疾病活动的生物标志物。
J Invest Dermatol. 2017 Aug;137(8):1663-1670. doi: 10.1016/j.jid.2017.04.008. Epub 2017 Apr 24.
8
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.青少年局限性硬皮病外周血细胞因子和趋化因子谱：辅助性T细胞相关细胞因子谱
Semin Arthritis Rheum. 2015 Dec;45(3):284-93. doi: 10.1016/j.semarthrit.2015.06.006. Epub 2015 Jun 17.
9
Pediatric scleroderma: systemic or localized forms.小儿硬皮病：系统性或局限性。
Pediatr Clin North Am. 2012 Apr;59(2):381-405. doi: 10.1016/j.pcl.2012.03.011. Epub 2012 Apr 6.
10
Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study.甲氨蝶呤和皮质类固醇治疗局限性硬皮病：一项标准化的前瞻性纵向单中心研究。
J Rheumatol. 2012 Feb;39(2):286-94. doi: 10.3899/jrheum.110210. Epub 2012 Jan 15.